4.5	  Guidelines for classification and staging systems,
Recommendations,Strength rating
Do not subject men to prostate-specific antigen (PSA) testing without counselling them on   the potential risks and benefits.,Strong
Offer an individualised risk-adapted strategy for early detection to a well-informed man with   a life-expectancy of at least 10 to 15 years.,Weak
Offer early PSA testing to well-informed men at elevated risk of having PCa:  •   men from 50 years of age;  •   men from 45 years of age and a family history of PCa;  •   men of African descent from 45 years of age;  •   men carrying BRCA2 mutations from 40 years of age.,Strong
